Halogen substituted benzodiazepine derivatives

Details for Australian Patent Application No. 2005299031 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Thomas, Andrew William; Knust, Henner

Agent Spruson & Ferguson

Pub. Number AU-B-2005299031

PCT Pub. Number WO2006/045429

Priority 04105167.3 20.10.04 EP

Filing date 11 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 10 November 2011

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/045429 Priority application(s): WO2006/045429

10 November 2011 Application Accepted

  Published as AU-B-2005299031

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299032-Imidazo-benzodiazepine derivatives

2005299030-Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide